i~HD Inaugural Conference

10 March 2016, Paris, France.
i~HD is a not-for-profit European institute, with a mission to guide and catalyse the quality, interoperability and trustworthy uses of health data, for optimising health and knowledge discovery. This Inaugural Conference will mark the parallel launch of a novel European platform to support multi-centre clinical research. This operational platform, the result of the European project EHR4CR (Electronic Health Records for Clinical Research), can connect securely to the data within multiple hospital EHR systems and clinical data warehouses across Europe, to enable a trial sponsor to predict the number of eligible patients for a candidate clinical trial protocol, to assess its feasibility and to locate the most relevant hospital sites.

The deep aim of this initiative is to provide patients with faster access to safe and efective medicines, improving health outcomes across Europe. This will be feasible by accelerating the development and achieving best practice that is patient-centered, leveraging personalized medicine for better patient care and a more inclusive route to inclusion in clinical trials. Eventually, it will lead to enhanced treatment options, giving patients faster access to innovative medicines and more personalised care pathways.

i~HD is an outcome and sustainability of projects from the European Innovative Medicines Initiative (IMI) and the European Commission's Seventh Framework Programme. It will enable, coordinate, and accelerate the eficient development and deployment of interoperable and seamless eHealth solutions and research strategies, towards achieving best practices and sustainable integrated person-centered health care, to optimize health and wellness in Europe, and beyond.

This inaugural conference will present the IMI EHR4CR platform and its adoption programme for 2016. It will also spotlight the challenges and state-of-the-art approaches to improving the quality and semantic interoperability of clinical data. The conference will include patient's perspective on the benefits of reusing their data for research presented by Mary Baker, former President of the European Brain Council, one of the keynote speakers.

The conference will take place at University Paris 6, Campus Les Cordeliers in Paris and is open to healthcare providers from across Europe, to EFPIA members, patient associations, health professional associations, the health ICT industry, and standards bodies.

For further information, please visit:
http://www.i-hd.eu

The event is being organized by i-HD in collaboration with AP-HP, EuroRec, RAMIT and Sano­fi and AstraZenica.

About i~HD

The European Institute for Innovation through Health Data (i~HD) has been formed as one of the key sustainable entities arising from the Electronic Health Records for Clinical Research (EHR4CR) and SemanticHealthNet projects, in collaboration with several other European projects and initiatives supported by the European Commission.

Most Popular Now

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...